{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:26:02Z","timestamp":1795188362269,"version":"4.10.3"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1038\/s41440-023-01392-x","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T05:02:31Z","timestamp":1690952551000},"page":"2635-2645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort"],"prefix":"10.1038","volume":"46","author":[{"given":"Marenao","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Inyaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagisa","family":"Hanawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"key":"1392_CR1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2018.05.074","volume":"72","author":"LD Colantonio","year":"2018","unstructured":"Colantonio LD, Booth JN 3rd, Bress AP, Whelton PK, Shimbo D, Levitan EB, et al. 2017 ACC\/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk. J Am Coll Cardiol. 2018;72:1187\u201397.","journal-title":"J Am Coll Cardiol"},{"key":"1392_CR2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"1392_CR3","doi-asserted-by":"crossref","unstructured":"Collaboration NCDRF. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380.","DOI":"10.1016\/S0140-6736(21)01330-1"},{"key":"1392_CR4","first-page":"e1046","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1046\u2013e81.","journal-title":"Circulation."},{"key":"1392_CR5","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/ckj\/sfac111","volume":"15","author":"A Osanami","year":"2022","unstructured":"Osanami A, Tanaka M, Furuhashi M, Ohnishi H, Hanawa N, Yamashita T, et al. Increased LDL-cholesterol level is associated with deterioration of renal function in males. Clin Kidney J. 2022;15:1888\u201395.","journal-title":"Clin Kidney J"},{"key":"1392_CR6","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/S0022-2275(20)37557-X","volume":"37","author":"JR McNamara","year":"1996","unstructured":"McNamara JR, Small DM, Li Z, Schaefer EJ. Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B. J Lipid Res. 1996;37:1924\u201335.","journal-title":"J Lipid Res"},{"key":"1392_CR7","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","volume":"43","author":"KK Berneis","year":"2002","unstructured":"Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002;43:1363\u201379.","journal-title":"J Lipid Res"},{"key":"1392_CR8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem"},{"key":"1392_CR9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","volume":"5","author":"M Sampson","year":"2020","unstructured":"Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and\/or Hypertriglyceridemia. JAMA Cardiol. 2020;5:540\u20138.","journal-title":"JAMA Cardiol"},{"key":"1392_CR10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5551\/jat.RV17023","volume":"25","author":"T Hirano","year":"2018","unstructured":"Hirano T. Pathophysiology of Diabetic Dyslipidemia. J Atheroscler Thromb. 2018;25:771\u201382.","journal-title":"J Atheroscler Thromb"},{"key":"1392_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1373\/clinchem.2010.149559","volume":"57","author":"Y Ito","year":"2011","unstructured":"Ito Y, Fujimura M, Ohta M, Hirano T. Development of a homogeneous assay for measurement of small dense LDL cholesterol. Clin Chem. 2011;57:57\u201365.","journal-title":"Clin Chem"},{"key":"1392_CR12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5551\/jat.12.67","volume":"12","author":"T Hirano","year":"2005","unstructured":"Hirano T, Ito Y, Yoshino G. Measurement of small dense low-density lipoprotein particles. J Atheroscler Thromb. 2005;12:67\u201372.","journal-title":"J Atheroscler Thromb"},{"key":"1392_CR13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12944-017-0417-6","volume":"16","author":"T Hayashi","year":"2017","unstructured":"Hayashi T, Koba S, Ito Y, Hirano T. Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels. Lipids Health Dis. 2017;16:21.","journal-title":"Lipids Health Dis"},{"key":"1392_CR14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/clinchem\/hvab048","volume":"67","author":"M Sampson","year":"2021","unstructured":"Sampson M, Wolska A, Warnick R, Lucero D, Remaley AT. A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test. Clin Chem. 2021;67:987\u201397.","journal-title":"Clin Chem"},{"key":"1392_CR15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/qjmed\/95.3.165","volume":"95","author":"MJ Landray","year":"2002","unstructured":"Landray MJ, Edmunds E, Li-Saw-Hee FL, Hughes BA, Beevers DG, Kendall MJ, et al. Abnormal low-density lipoprotein subfraction profile in patients with untreated hypertension. QJM. 2002;95:165\u201371.","journal-title":"QJM."},{"key":"1392_CR16","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/jhh.2011.86","volume":"26","author":"YK Kim","year":"2012","unstructured":"Kim YK, Seo HS, Lee EM, Na JO, Choi CU, Lim HE, et al. Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome. J Hum Hypertens. 2012;26:670\u20136.","journal-title":"J Hum Hypertens"},{"key":"1392_CR17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/HJH.0000000000002678","volume":"39","author":"HW Zhang","year":"2021","unstructured":"Zhang HW, Jin JL, Cao YX, Liu HH, Zhang Y, Guo YL, et al. Association of small dense LDL-cholesterol with disease severity, hypertension status and clinical outcome in patients with coronary artery disease. J Hypertens. 2021;39:511\u20138.","journal-title":"J Hypertens"},{"key":"1392_CR18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"1392_CR19","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc17-S005","volume":"40","author":"American Diabetes Association.","year":"2017","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2017;40:S11\u2013S24.","journal-title":"Diabetes Care"},{"key":"1392_CR20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics."},{"key":"1392_CR21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11\u201321.","journal-title":"Stat Med"},{"key":"1392_CR22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/aje\/kws207","volume":"176","author":"MJ Pencina","year":"2012","unstructured":"Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol. 2012;176:473\u201381.","journal-title":"Am J Epidemiol"},{"key":"1392_CR23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"1392_CR24","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/eurheartj\/ehn061","volume":"29","author":"DE Laaksonen","year":"2008","unstructured":"Laaksonen DE, Niskanen L, Nyyssonen K, Lakka TA, Laukkanen JA, Salonen JT. Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J. 2008;29:2561\u20138.","journal-title":"Eur Heart J"},{"key":"1392_CR25","doi-asserted-by":"crossref","first-page":"e021430","DOI":"10.1161\/JAHA.121.021430","volume":"10","author":"Y Higashiura","year":"2021","unstructured":"Higashiura Y, Furuhashi M, Tanaka M, Takahashi S, Mori K, Miyamori D, et al. Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10-Year Period in Both Male and Female Subjects. J Am Heart Assoc. 2021;10:e021430.","journal-title":"J Am Heart Assoc"},{"key":"1392_CR26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41440-023-01179-0","volume":"46","author":"K Mori","year":"2023","unstructured":"Mori K, Tanaka M, Hosaka I, Mikami T, Endo K, Hanawa N, et al. Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: Linear mixed-effects model analyses. Hypertens Res. 2023;46:1110\u201321.","journal-title":"Hypertens Res"},{"key":"1392_CR27","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/HJH.0000000000000941","volume":"34","author":"L Sanchez-Inigo","year":"2016","unstructured":"Sanchez-Inigo L, Navarro-Gonzalez D, Pastrana-Delgado J, Fernandez-Montero A, Martinez JA. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort. J Hypertens. 2016;34:1257\u201365.","journal-title":"J Hypertens"},{"key":"1392_CR28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.numecd.2020.11.026","volume":"31","author":"D He","year":"2021","unstructured":"He D, Fan F, Jia J, Jiang Y, Sun P, Wu Z, et al. Lipid profiles and the risk of new-onset hypertension in a Chinese community-based cohort. Nutr Metab Cardiovasc Dis. 2021;31:911\u201320.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1392_CR29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/HJH.0000000000002693","volume":"39","author":"Y Tomita","year":"2021","unstructured":"Tomita Y, Sakata S, Arima H, Yamato I, Ibaraki A, Ohtsubo T, et al. Relationship between casual serum triglyceride levels and the development of hypertension in Japanese. J Hypertens. 2021;39:677\u201382.","journal-title":"J Hypertens"},{"key":"1392_CR30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7326\/0003-4819-149-10-200811180-00009","volume":"149","author":"H Janes","year":"2008","unstructured":"Janes H, Pepe MS, Gu W. Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med. 2008;149:751\u201360.","journal-title":"Ann Intern Med"},{"key":"1392_CR31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB Sr, D\u2019Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157\u201372. discussion 207-12","journal-title":"Stat Med"},{"key":"1392_CR32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-150-11-200906020-00007","volume":"150","author":"NR Cook","year":"2009","unstructured":"Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009;150:795\u2013802.","journal-title":"Ann Intern Med"},{"key":"1392_CR33","doi-asserted-by":"crossref","first-page":"905504","DOI":"10.3389\/fcvm.2022.905504","volume":"9","author":"T Tasic","year":"2022","unstructured":"Tasic T, Tadic M, Lozic M. Hypertension in Women. Front Cardiovasc Med. 2022;9:905504.","journal-title":"Front Cardiovasc Med"},{"key":"1392_CR34","doi-asserted-by":"publisher","unstructured":"Azizi Z, Alipour P, Raparelli V, Norris CM, Pilote L. The role of sex and gender in hypertension. J Hum Hypertens. 2022. https:\/\/doi.org\/10.1038\/s41371-022-00789-4.","DOI":"10.1038\/s41371-022-00789-4"},{"key":"1392_CR35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41440-020-0532-z","volume":"44","author":"K Mori","year":"2021","unstructured":"Mori K, Furuhashi M, Tanaka M, Numata K, Hisasue T, Hanawa N, et al. U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2. Hypertens Res. 2021;44:107\u201316.","journal-title":"Hypertens Res"},{"key":"1392_CR36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41440-021-00792-1","volume":"45","author":"K Mori","year":"2022","unstructured":"Mori K, Furuhashi M, Tanaka M, Higashiura Y, Koyama M, Hanawa N, et al. Serum uric acid level is associated with an increase in systolic blood pressure over time in female subjects: Linear mixed-effects model analyses. Hypertens Res. 2022;45:344\u201353.","journal-title":"Hypertens Res"},{"key":"1392_CR37","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/ndt\/gfu197","volume":"29","author":"H Akasaka","year":"2014","unstructured":"Akasaka H, Yoshida H, Takizawa H, Hanawa N, Tobisawa T, Tanaka M, et al. The impact of elevation of serum uric acid level on the natural history of glomerular filtration rate (GFR) and its sex difference. Nephrol Dial Transpl. 2014;29:1932\u20139.","journal-title":"Nephrol Dial Transpl"},{"key":"1392_CR38","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","volume":"319","author":"M Furuhashi","year":"2020","unstructured":"Furuhashi M. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab. 2020;319:E827\u2013E34.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1392_CR39","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1253\/circj.CJ-18-0082","volume":"82","author":"M Furuhashi","year":"2018","unstructured":"Furuhashi M, Matsumoto M, Tanaka M, Moniwa N, Murase T, Nakamura T, et al. Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population. Circ J. 2018;82:1892\u20139.","journal-title":"Circ J"},{"key":"1392_CR40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1507\/endocrj.EJ19-0053","volume":"66","author":"M Furuhashi","year":"2019","unstructured":"Furuhashi M, Koyama M, Matsumoto M, Murase T, Nakamura T, Higashiura Y, et al. Annual change in plasma xanthine oxidoreductase activity is associated with changes in liver enzymes and body weight. Endocr J. 2019;66:777\u201386.","journal-title":"Endocr J"},{"key":"1392_CR41","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jdi.12982","volume":"10","author":"M Furuhashi","year":"2019","unstructured":"Furuhashi M, Matsumoto M, Murase T, Nakamura T, Higashiura Y, Koyama M, et al. Independent links between plasma xanthine oxidoreductase activity and levels of adipokines. J Diabetes Investig. 2019;10:1059\u201367.","journal-title":"J Diabetes Investig"},{"key":"1392_CR42","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/s41440-021-00679-1","volume":"44","author":"M Furuhashi","year":"2021","unstructured":"Furuhashi M, Higashiura Y, Koyama M, Tanaka M, Murase T, Nakamura T, et al. Independent association of plasma xanthine oxidoreductase activity with hypertension in nondiabetic subjects not using medication. Hypertens Res. 2021;44:1213\u201320.","journal-title":"Hypertens Res"},{"key":"1392_CR43","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1507\/endocrj.EJ18-0127","volume":"65","author":"M Furuhashi","year":"2018","unstructured":"Furuhashi M, Mori K, Tanaka M, Maeda T, Matsumoto M, Murase T, et al. Unexpected high plasma xanthine oxidoreductase activity in female subjects with low levels of uric acid. Endocr J. 2018;65:1083\u201392.","journal-title":"Endocr J"},{"key":"1392_CR44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-2275(20)32065-4","volume":"41","author":"CJ Packard","year":"2000","unstructured":"Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G, et al. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res. 2000;41:305\u201318.","journal-title":"J Lipid Res"},{"key":"1392_CR45","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/01.ATV.17.4.786","volume":"17","author":"S Goulinet","year":"1997","unstructured":"Goulinet S, Chapman MJ. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol. 1997;17:786\u201396.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1392_CR46","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.ATV.19.3.810","volume":"19","author":"L Chancharme","year":"1999","unstructured":"Chancharme L, Therond P, Nigon F, Lepage S, Couturier M, Chapman MJ. Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. Arterioscler Thromb Vasc Biol. 1999;19:810\u201320.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1392_CR47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1573403X12666160126115317","volume":"12","author":"BM Antunes","year":"2016","unstructured":"Antunes BM, Cayres SU, Lira FS, Fernandes RA. Arterial Thickness and Immunometabolism: The Mediating role of Chronic Exercise. Curr Cardiol Rev. 2016;12:47\u201351.","journal-title":"Curr Cardiol Rev"},{"key":"1392_CR48","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5551\/jat.11445","volume":"19","author":"S Maeda","year":"2012","unstructured":"Maeda S, Nakanishi S, Yoneda M, Awaya T, Yamane K, Hirano T, et al. Associations between small dense LDL, HDL subfractions (HDL2, HDL3) and risk of atherosclerosis in Japanese-Americans. J Atheroscler Thromb. 2012;19:444\u201352.","journal-title":"J Atheroscler Thromb"},{"key":"1392_CR49","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.5551\/jat.54130","volume":"27","author":"H Ikezaki","year":"2020","unstructured":"Ikezaki H, Furusyo N, Yokota Y, Ai M, Asztalos BF, Murata M, et al. Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression. J Atheroscler Thromb. 2020;27:1108\u201322.","journal-title":"J Atheroscler Thromb"},{"key":"1392_CR50","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/jama.1988.03410130125037","volume":"260","author":"MA Austin","year":"1988","unstructured":"Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917\u201321.","journal-title":"JAMA"},{"key":"1392_CR51","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/eurheartj\/ehm390","volume":"28","author":"BJ Arsenault","year":"2007","unstructured":"Arsenault BJ, Lemieux I, Despres JP, Wareham NJ, Luben R, Kastelein JJ, et al. Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study. Eur Heart J. 2007;28:2770\u20137.","journal-title":"Eur Heart J"},{"key":"1392_CR52","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2006.09.043","volume":"49","author":"K El Harchaoui","year":"2007","unstructured":"El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, et al. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol. 2007;49:547\u201353.","journal-title":"J Am Coll Cardiol"},{"key":"1392_CR53","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/ATVBAHA.113.302401","volume":"34","author":"MY Tsai","year":"2014","unstructured":"Tsai MY, Steffen BT, Guan W, McClelland RL, Warnick R, McConnell J, et al. New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34:196\u2013201.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1392_CR54","doi-asserted-by":"crossref","first-page":"669","DOI":"10.5551\/jat.51961","volume":"27","author":"M Higashioka","year":"2020","unstructured":"Higashioka M, Sakata S, Honda T, Hata J, Yoshida D, Hirakawa Y, et al. Small Dense Low-Density Lipoprotein Cholesterol and the Risk of Coronary Heart Disease in a Japanese Community. J Atheroscler Thromb. 2020;27:669\u201382.","journal-title":"J Atheroscler Thromb"},{"key":"1392_CR55","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/hr.2014.111","volume":"37","author":"M Takiwaki","year":"2014","unstructured":"Takiwaki M, Tomoda F, Koike T, Taki T, Inoue H, Kigawa M, et al. Increased levels of small dense low-density lipoprotein cholesterol associated with hemorheological abnormalities in untreated, early-stage essential hypertensives. Hypertens Res. 2014;37:1008\u201313.","journal-title":"Hypertens Res"},{"key":"1392_CR56","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/bmj.322.7291.912","volume":"322","author":"G Beevers","year":"2001","unstructured":"Beevers G, Lip GY, O'Brien E. ABC of hypertension: The pathophysiology of hypertension. BMJ 2001;322:912\u20136.","journal-title":"BMJ"},{"key":"1392_CR57","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrcardio.2017.155","volume":"15","author":"ME Safar","year":"2018","unstructured":"Safar ME. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol. 2018;15:97\u2013105.","journal-title":"Nat Rev Cardiol"},{"key":"1392_CR58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111\u201388.","journal-title":"Eur Heart J"},{"key":"1392_CR59","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/HYPERTENSIONAHA.121.17981","volume":"78","author":"G Jia","year":"2021","unstructured":"Jia G, Sowers JR. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension 2021;78:1197\u2013205.","journal-title":"Hypertension"},{"key":"1392_CR60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00041433-199506000-00007","volume":"6","author":"MR Taskinen","year":"1995","unstructured":"Taskinen MR. Insulin resistance and lipoprotein metabolism. Curr Opin Lipido. 1995;6:153\u201360.","journal-title":"Curr Opin Lipido"},{"key":"1392_CR61","doi-asserted-by":"publisher","unstructured":"Hirano T, Ito Y. Accuracy of Small Dense Low-density Lipoprotein-cholesterol Concentration Estimated via Sampson\u2019s Equation in Healthy Subjects and Patients with Diabetes. J Atheroscler Thromb. 2022. https:\/\/doi.org\/10.5551\/jat.63865.","DOI":"10.5551\/jat.63865"},{"key":"1392_CR62","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/HCO.0000000000000411","volume":"32","author":"A Jain","year":"2017","unstructured":"Jain A, Puri R, Nair DR. South Asians: why are they at a higher risk for cardiovascular disease? Curr Opin Cardiol. 2017;32:430\u20136.","journal-title":"Curr Opin Cardiol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01392-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01392-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01392-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T19:02:54Z","timestamp":1701716574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01392-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1392"],"URL":"https:\/\/doi.org\/10.1038\/s41440-023-01392-x","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"4 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}